Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP866832.RAfulcX07b7pNF14mSno_5W0ULpD0c1PcWP9143S657LQ130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866832.RAfulcX07b7pNF14mSno_5W0ULpD0c1PcWP9143S657LQ130_provenance.
• NP889468.RAQAj_0ZwVOnqibTwtH91MWDXfnL0na0SlADlv5Ljm5-4130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889468.RAQAj_0ZwVOnqibTwtH91MWDXfnL0na0SlADlv5Ljm5-4130_provenance.
• NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_provenance.
• NP469263.RAARfmfSjcN6CFKeFnMYihVvBeaIjrMTdfRWIPGZr2X5M130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469263.RAARfmfSjcN6CFKeFnMYihVvBeaIjrMTdfRWIPGZr2X5M130_provenance.
• NP651800.RAdMpZYmDnS3EGfzC0JhGXdEU5dGX1zTYtJ6h3tznM74s130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651800.RAdMpZYmDnS3EGfzC0JhGXdEU5dGX1zTYtJ6h3tznM74s130_provenance.
• NP469261.RAV3q4XvoYNDFMfQxNCVHv2TKYrc71clUzXFPWXXOFocI130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469261.RAV3q4XvoYNDFMfQxNCVHv2TKYrc71clUzXFPWXXOFocI130_provenance.
• NP469262.RAV1-Kdk6qdXiiBuHcVtnVIcQdYcEL5WwPDjNyOnQhlz8130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469262.RAV1-Kdk6qdXiiBuHcVtnVIcQdYcEL5WwPDjNyOnQhlz8130_provenance.
• NP651861.RAKmheQCe-EVnQise6jcFSzCY6K4pXSlSTDYyEnjlzotc130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651861.RAKmheQCe-EVnQise6jcFSzCY6K4pXSlSTDYyEnjlzotc130_provenance.
• NP651913.RANmGKmEf0j4ynaJxYOsZj9gBpE8QUB1vUGh8coGD9PA0130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651913.RANmGKmEf0j4ynaJxYOsZj9gBpE8QUB1vUGh8coGD9PA0130_provenance.
• NP651920.RAHB8AYqvrSemF683tGZQdBwvCxeQm6xLNPBQCeegUByY130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651920.RAHB8AYqvrSemF683tGZQdBwvCxeQm6xLNPBQCeegUByY130_provenance.
• assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP469265.RAIdgQYcP3IBUxZAgsH7PVe1TsfcIXZ3DW_YNWo7RXDI0130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469265.RAIdgQYcP3IBUxZAgsH7PVe1TsfcIXZ3DW_YNWo7RXDI0130_provenance.
• NP469266.RAExsHvtT5Vw1DSkYkMvyj4MCvkL62e6EySme-mAT4ddY130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469266.RAExsHvtT5Vw1DSkYkMvyj4MCvkL62e6EySme-mAT4ddY130_provenance.
• assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP991916.RAGFwPNzNroCn8kofGQykezMddHjrCb_fn15ehRHpO3iA130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991916.RAGFwPNzNroCn8kofGQykezMddHjrCb_fn15ehRHpO3iA130_provenance.
• NP651873.RAmcg76U7hTpCIviua5ZcSKBU-8_EwiautGBJ_ZYthvUY130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651873.RAmcg76U7hTpCIviua5ZcSKBU-8_EwiautGBJ_ZYthvUY130_provenance.
• NP469259.RAudkvfQgIfiLQGk9enPG4kFjQASIgg6pluRIvwAJTd2w130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469259.RAudkvfQgIfiLQGk9enPG4kFjQASIgg6pluRIvwAJTd2w130_provenance.